Teresita de Jesús Villaseñor Cabrera

Prof. Teresita de Jesús Villaseñor Cabrera

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2024 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
EVEdgar Ricardo Valdivia-Tangarife
Edgar Ricardo Valdivia-Tangarife
AMAlejandra Morlett-Paredes
Alejandra Morlett-Paredes
GRGenoveva Rizo-Curiel
Genoveva Rizo-Curiel
MJMiriam E. Jiménez-Maldonado
Miriam E. Jiménez-Maldonado
JRJose Luis Ruiz-Sandoval
Jose Luis Ruiz-Sandoval
TCTeresita de Jesús Villaseñor Cabrera
Teresita de Jesús Villaseñor Cabrera

1 April 2025 in Multiple Sclerosis Journal – Experimental, Translational and Clinical
Verified
Journal Article
Open access
MJMiriam E Jiménez-Maldonado
Miriam E Jiménez-Maldonado
EVEdgar Ricardo Valdivia-Tangarife
Edgar Ricardo Valdivia-Tangarife
MMMiguel Ángel Macías-Islas
Miguel Ángel Macías-Islas
FCFernando Cortés-Enríquez
Fernando Cortés-Enríquez
AMAlejandra Morlett-Paredes
Alejandra Morlett-Paredes
TCTeresita de Jesús Villaseñor Cabrera
Teresita de Jesús Villaseñor Cabrera
Background: The present review aimed to identify published studies that reported the validation of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) in Latin America (LATAM). Methods: To compile a comprehensive list of available validation studies, we performed a systematic review of the literature via an electronic search of PubMed and Web of Science via the keywords “Validation,” “Brief Cognitive Assessment for Multiple Sclerosis,” “BICAMS,” and “Latin America.” Results: Twenty-seven sources of validation studies for the BICAMS were identified. Of the 27 citations identified, only four provide validation of the BICAMS in LATAM. These studies include a comparison of cognitive performance between multiple sclerosis (MS) patients and healthy controls (HCs) across all three BICAMS tests. Overall, the studies included a greater proportion of patients with RRMS and middle-aged adults and included participants with wide ranges of education levels. Conclusion: We provide a detailed description of the BICAMS validation currently available for people living in LATAM. Although the validation of tests in diverse populations has gained interest in the field, there is still a need for more studies among people from LATAM countries.

1 July 2025 in Multiple Sclerosis Journal – Experimental, Translational and Clinical
Verified
Journal Article
Open access
EVEdgar Ricardo Valdivia-Tangarife
Edgar Ricardo Valdivia-Tangarife
FGFabiola Gonzalez-Ponce
Fabiola Gonzalez-Ponce
AMAlejandra Morlett-Paredes
Alejandra Morlett-Paredes
JMJazmin Marquez-Pedroza
Jazmin Marquez-Pedroza
TCTeresita de Jesús Villaseñor Cabrera
Teresita de Jesús Villaseñor Cabrera
EVEdgar Ricardo Valdivia-Tangarife
Edgar Ricardo Valdivia-Tangarife
Background: Patients with neuromyelitis optica spectrum disorders (NMOSD) often experience significant functional limitation, high rates of disability, and cognitive impairment (CI). The objective of this study was evaluating the factors associated with CI in patients diagnosed with NMOSD in Mexico. Methods: The study was cross-sectional in design. We included 65 NMOSD patients (34 NMOSD with CI and 31 NMOSD without CI). We utilized the Brief International Cognitive Assessment for Multiple Sclerosis to identify CI in NMOSD patients. Logistic regression was applied to identify the factors associated with CI. Results: Factors associated with CI in the crude analysis were education level (⩽6 years of schooling; odds ratio (OR) 4.37, 95% confidence interval (CI) 1.41–13.52, p = 0.010), disease duration (⩾60 months; OR 8.22, 95% CI 2.68–25.20, p < 0.001), time from onset to diagnosis (⩾12 months; OR 3.70, 95% CI 1.21–11.31, p = 0.022), brain lesion (on magnetic resonance imaging before azathioprine or rituximab; OR 3.46, 95% CI 1.20–10.00, p = 0.022), and relapses by NMOSD diagnosis (⩾4; OR 4.48, 95% CI 1.57–12.76, p = 0.005). Factors associated with CI in the adjusted analyses were education (⩽6 years; OR 5.92, 95% CI 1.57–22.23, p = 0.008), disease duration (⩾60 months; OR 5.73, 95% CI 1.69–19.40, p = 0.005), and relapses by NMOSD diagnosis (⩾4; OR 5.79, 95% CI 1.70–19.72, p = 0.005). Conclusion: One of the biggest factors associated with CI was relapse by NMOSD, specifically those with lower education levels and those with longer disease duration.

12 July 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
NRNayeli Alejandra Sánchez Rosales
Nayeli Alejandra Sánchez Rosales
EVEdgar Ricardo Valdivia-Tangarife
Edgar Ricardo Valdivia-Tangarife
BTBlanca Miriam Torres-Mendoza
Blanca Miriam Torres-Mendoza
AKAntonio Kobayashi-Gutiérrez
Antonio Kobayashi-Gutiérrez
FFFrancisco Javier Frías-Márquez
Francisco Javier Frías-Márquez
JMJazmin Marquez-Pedroza
Jazmin Marquez-Pedroza
Progression independent of relapse activity (PIRA) and smouldering multiple sclerosis (MS) represent major unmet challenges in contemporary MS care. Disability may accumulate independently of clinical relapses, driven in part by chronic compartmentalised inflammation behind a relatively intact blood–brain barrier and incompletely captured by conventional monitoring tools. This narrative review synthesises evidence across four complementary biomarker domains for detecting smouldering MS and PIRA: advanced MRI (paramagnetic rim lesions [PRLs], slowly expanding lesions, deep grey matter atrophy, quantitative susceptibility mapping); fluid biomarkers (serum glial fibrillary acidic protein [sGFAP], serum neurofilament light chain [sNfL]); retinal optical coherence tomography (ganglion cell–inner plexiform layer thinning); and digital health metrics (wearable accelerometry, digital Symbol Digit Modalities Test). In a single prospective cohort, combined elevation of sGFAP and sNfL conferred a 4.71-fold increased hazard for PIRA (HR 4.71; 95% CI 2.05–9.77); independent data suggest sGFAP may carry selectivity for progression beyond sNfL, although this remains to be confirmed. No single domain sufficiently characterises smouldering pathology. We therefore propose a hypothesis-generating Multimodal PIRA Score (MPS) as a conceptual validation scaffold intended to structure—rather than inform—prospective multicentre evaluation against a long-horizon disability endpoint. Harmonisation of acquisition protocols, reference ranges, and digital phenotyping algorithms remains a prerequisite.

27 November 2023 in Atos de Pesquisa em Educação
Verified
Journal Article
Open access
PDF file
LCLynn Clouder
Lynn Clouder
SJSusana Aurelia Preciado Jimenez
Susana Aurelia Preciado Jimenez
DMDiego Di Masi
Diego Di Masi
MSMarie Sams
Marie Sams
TCTeresita de Jesús Villaseñor Cabrera
Teresita de Jesús Villaseñor Cabrera
ANAna Verônica Naranjo
Ana Verônica Naranjo
This paper presents findings from the ENTENDER Erasmus+ Capacity Building in Higher Education (CBHE) project (funded by the European Union Commission) involving five Latin American (LA) universities in Argentina and Mexico and three European partner universities. The project aimed to raise awareness of neurodiversity, create processes and tools to identify neurodivergent students’ learning needs and promote teacher training to design and provide inclusive learning environments. A collaborative cocreation approach was implemented. All elements of the project were evaluated against a baseline via a needs analysis. We discuss the initial challenges, the gains, and the unexpected outcomes that have propelled neurodiversity to the top of the agenda in the partner institutions initiating a change in attitudes from a deficit model to a strengths-based focus.

26 February 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
TCTeresita de Jesús Villaseñor Cabrera
Teresita de Jesús Villaseñor Cabrera
MMMiguel Ángel Macías-Islas
Miguel Ángel Macías-Islas
KSKaren Anette Sanchez-Jacuinde
Karen Anette Sanchez-Jacuinde
GRGenoveva Rizo-Curiel
Genoveva Rizo-Curiel
MJMiriam E. Jiménez-Maldonado
Miriam E. Jiménez-Maldonado
EVEdgar Ricardo Valdivia-Tangarife
Edgar Ricardo Valdivia-Tangarife
Background: The Perri Auditory Verbal Learning Test (Perri-AVLT) is a cognitive tool designed to assess verbal learning and memory. Currently, demographically adjusted norms for the Perri-AVLT are not available for elderly Mexican adults. Objective: This study aimed to develop regression-based norms from elderly Mexican adults to enable demographic adjustments for clinical interpretation. Methods: The sample included 294 elderly Mexican adults aged 60–89 (224 cognitively normal individuals, and 70 clinical cases) from Mexico (Jalisco, Guanajuato, and Mexico City). Participants were administered the Perri-AVLT. A multivariate regression-based norming approach was used to evaluate the effects of age, sex, and years of education on test performance. Results: The multivariate regression model showed that years of education were a significant predictor of cognitive performance across all Perri-AVLT trials. The Pearson correlation for all Perri-AVLT trials was high. Conclusion: This study provides regression-based normative data for the Perri-AVLT adjusted for sociodemographic factors. These norms can be used to evaluate verbal learning and memory in elderly Mexican adults. This information can support a neuropsychologist in cognitive assessment, rehabilitation, and research.